0001209191-19-005449.txt : 20190125
0001209191-19-005449.hdr.sgml : 20190125
20190125203533
ACCESSION NUMBER: 0001209191-19-005449
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190124
FILED AS OF DATE: 20190125
DATE AS OF CHANGE: 20190125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Afdhal Nezam H.
CENTRAL INDEX KEY: 0001664569
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37718
FILM NUMBER: 19543697
MAIL ADDRESS:
STREET 1: C/O SPRING BANK PHARMACEUTICALS, INC.
STREET 2: 113 CEDAR STREET, SUITE S-7
CITY: MILFORD
STATE: MA
ZIP: 01757
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Spring Bank Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001566373
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 522386345
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 PARKWOOD DRIVE
STREET 2: SUITE 210
CITY: HOPKINTON
STATE: MA
ZIP: 01748
BUSINESS PHONE: 508-473-5993 X119
MAIL ADDRESS:
STREET 1: 35 PARKWOOD DRIVE
STREET 2: SUITE 210
CITY: HOPKINTON
STATE: MA
ZIP: 01748
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-24
0
0001566373
Spring Bank Pharmaceuticals, Inc.
SBPH
0001664569
Afdhal Nezam H.
C/O SPRING BANK PHARMACEUTICALS, INC.
35 PARKWOOD DRIVE
HOPKINTON
MA
01748
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
10.35
2019-01-24
4
A
0
50000
0.00
A
2029-01-24
Common Stock
50000
50000
D
This option was granted on January 24, 2019, with 25% of the shares subject to the option vesting on January 24, 2020 and the remaining 75% of the shares subject to the option vesting in 36 equal monthly installments thereafter.
/s/ Lori Firmani, Attorney-in-Fact
2019-01-25